Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial

Matthew Zibelman, Aeen M. Asghar, Daniel C. Parker, John O'Neill, Shuanzeng Wei, Richard E. Greenberg, Marc C. Smaldone, David Y.T. Chen, Rosalia Viterbo, Robert G. Uzzo, Evan Bloom, Rutika Kokate, Daniel M. Geynisman, Pooja Ghatalia, Mengying Deng, Eric A. Ross, Elizabeth Plimack, Philip H. Abbosh, Alexander Kutikov

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Purpose:Concern for discordance between clinical staging and final pathology drives current management of patients deemed appropriate candidates for radical cystectomy. Therefore, we set out to prospectively investigate reliability and shortcomings of cystoscopic evaluation in radical cystectomy candidates.Materials and Methods:Patients undergoing radical cystectomy for urothelial carcinoma were enrolled in a prospective single-arm study to evaluate reliability of Systematic Endoscopic Evaluation in predicting pT0 urothelial carcinoma (NCT02968732). Systematic Endoscopic Evaluation consisted of cystoscopy and tissue sampling at the time of radical cystectomy. Systematic Endoscopic Evaluation results were compared to radical cystectomy pathology. The primary end point was the negative predictive value of Systematic Endoscopic Evaluation findings in predicting radical cystectomy pathology.Results:A total of 61 patients underwent Systematic Endoscopic Evaluation and radical cystectomy. Indications included muscle invasive bladder cancer in 42 (68.9%) and high risk nonmuscle invasive bladder cancer in 19 (31.1%). In all, 38 (62.3%, 90.5% of patients with muscle invasive bladder cancer) received neoadjuvant chemotherapy. On Systematic Endoscopic Evaluation, 31 (50.8%) patients demonstrated no visual nor biopsy-based evidence of disease (seeT0), yet 16/31 (51.6%) harbored residual disease (>pT0), including 8 (8/31, 25.8%) with residual ≥pT2 disease upon radical cystectomy. The negative predictive value of Systematic Endoscopic Evaluation predicting a pT0 bladder was 48.4% (CI 30.2-66.9), which was below our prespecified hypothesis. Therefore, the trial was stopped for futility.Conclusions:Approximately 1 of 4 patients with seeT0 at the time of radical cystectomy harbored residual muscle invasive bladder cancer. These prospective data definitively confirm major limitations of endoscopic assessment for pT0 bladder cancer. Future work should focus on novel imaging and biomarker strategies to optimize evaluations before radical cystectomy for improved decision making regarding bladder preservation.

Original languageEnglish
Pages (from-to)1605-1611
Number of pages7
JournalJournal of Urology
Volume205
Issue number6
DOIs
StatePublished - Jun 1 2021

Keywords

  • Aged
  • Cystectomy
  • Cystoscopy
  • Female
  • Humans
  • Male
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prospective Studies
  • Reproducibility of Results
  • Specimen Handling
  • Urinary Bladder Neoplasms/pathology

Fingerprint

Dive into the research topics of 'Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial'. Together they form a unique fingerprint.

Cite this